Cytochromes P450 mediating the N-demethylation of amitriptyline

British Journal of Clinical Pharmacology

Volumn 43, Issue 2, 1997, Pages 137-144

  Ghahramani, P ^a   Ellis, S W ^a   Lennard, M S ^a   Ramsay, L E ^a   Tucker, G T ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Amitriptyline; CYP2D6; Cytochrome P450; N dealkylation

Indexed keywords

AMITRIPTYLINE; CYTOCHROME P450; DESIPRAMINE; DRUG METABOLITE; FURAFYLLINE; MEPHENYTOIN; NORTRIPTYLINE; QUINIDINE; SULFAPHENAZOLE;

ARTICLE; DEMETHYLATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIVER MICROSOME; LYMPHOBLASTOID CELL; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0031058342     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.05382.x     Document Type: Article

References (26)

1. Ballenger JC. Phamiacotherapy of panic disorders. J Clin Psychiatr 1986; 47(suppl.6): 27-32.
2. Rollins DE, Alvan G, Bertilsson L, et al. Intel-individual differences in amitriptyline demethylation. Clin Pharniacol Tlier 1988; 32: 664-667.
3. Mellstrom B, Alvan G, Bertilsson L, et al. Nortriptyline formation after single oral and intramuscular doses of amitriptyline. Clin Phannacol Tlier 1982; 32: 664-667.
4. Nordin C, Siwers B, Benitez J, Bertilsson L. Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients- Relationship to the debrisoquine hydroxylation metabolic ratio. BrJ Clin Phannacol 1985; 19: 832-835.
5. Mellstrom B, Bertilsson L, Sawe J, Schulz HU, Sjoqvist F. E-and Z-10-hydroxylation of nortriptyline: Relationship to polymorphic debrisoquine hydroxylation. Clin Phannacol Tlier 1981; 30: 189-193.
6. Balant-Gorgia AE, Schulz P, Dayer P, et al. Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in man. Arch Psychiatr Nervenkr 1982; 232: 215-222.
7. Woolhouse NM, Adjepon-Yamoah KK, Mellstrom B, et al. Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects. Clin Phannacol Tlier 1984; 36: 374-378.
8. Baumann P, Meyer JW, Amey M, et al. Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptyline. Tlier Dnig Moult 1992; 14: 1-8.
9. Mellstrom B, Sawe J, Bertilsson L, Sjoqvist F. Amitriptyline metabolism: Association with debrisoquine hydroxylation in nonsmokers. Clin Phannacol Tlier 1986; 39: 369-371.
10. Breyer-Pfaff U, Pfandl B, Mill K, et al. Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isoenzymes. Clin Phannacol Tlier 1992; 52: 350-358.
11. Lemoine A, Gautier JC, Azoulay D, et al. Major pathway of imipramine is catalysed by cytochromes P-450 1A2 and P-450 3A4 in human liver. Mol Phannacol 1993; 43: 827-832.
12. Otton SV, Crewe HK, Lennard MS, Tucker GT, Woods HF. Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes. J Phannacol Exp Tlier 1988; 247: 242-247.
13. Ellis SW, Ching MS, Watson PF, et al. Catalytic activity of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast. Biochem Phannacol 1992; 44: 617-620.
14. Rowland K, Ellis SW, Lennard MS, Tucker GT. Variable contribution of CYP2D6 to the N-dealkylation of S-(-)-propanolol by human liver microsomes. BrJ Clin Phannacol 1996; 42: 390-393.
15. Otton SV, Brinn RU, Gram LF. In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver. Dnig Metab Dispos 1988; 16: 15-17.
16. Ghahramani P, Lennard MS. Quantitative analysis of amitriptyline and nortriptyline in human plasma and liver microsomal preparations by high-performance liquid chromatography. J Chromatogr 1996; 685: 307-313.
17. Chang T, Gonzalez FJ, Waxman DJ. Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Arch Biochem Biopliys 1994; 311: 437-442.
18. Newton DJ, Wang RW, Lu A. Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Dnig Metab Dispos 1995; 23: 154-158.
19. von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Harmatz JS, Shader RI. Inhibitors of alprazolam metabolism in vitro: Effect of serotonin- reuptake-inhibitor antidepressants, ketoconazole and quinidine. BrJ Clin Pliannacol 1994; 38: 23-31.
20. Tassaneeyakul W, Birkett DJ, Veronese ME, et al. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J Phannaeol Exp Tlier 1993; 265: 401-407.
21. Schulz P, Dick P, Blaschke TF, Hollister L. Discrepancies between pharmacokinetic studies of amitriptyline. Clin Pliannacokin 1985; 10:257-268.
22. Silvers KJ, Chazinski T, McManus ME, et al. Cytochrome P-450 3A4 (nifedipine oxidase) is responsible for the C-oxidative metabolism of 1-nitropyrene in human liver microsmal samples. Cancer Res 1992; 52: 6237-6243.
23. Jurima-Romet M, Crawford K, Cyr T, Inaba T. Terfenadine metabolism in human liver-w vitro inhibition by macrolide antibiotics and azole antifungals. Dnig Metab Dispos 1994; 22: 849-857.
24. Jonsson G, Astrom A, Andersson P. Budenoside is metabolized by cytochrome-P450 3A (CYP3A4) enzymes in human liver. Dnig Metab Dispos 1995; 23: 137-142.
25. Schmider J, Greenblatt DJ, Harmatz JS, Shader RI. Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: application to amitriptyline N-demethylation. BrJ Ctin Phannaeol 1996; 41: 593-604.
26. Schmider J, Greenblatt DJ, von Moltke LL, Harmatz JS, Shader RI. AT-demethylation of amitriptyline in vitro: role of cytochrome P-4503A (CYP3A) isoforms and effect of metabolic inhibitors. J Pliannacol Exp Tlier 1995; 275: 592-597.